• レポートコード:GIR201103136 • 出版社/出版日:GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、107ページ • 納品方法:Eメール • 産業分類:医薬品・医療 |
Single User | ¥522,000 (USD3,480) | ▷ お問い合わせ |
Multi User | ¥783,000 (USD5,220) | ▷ お問い合わせ |
Corporate User | ¥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本書では、C-X-Cケモカイン受容体タイプ2の世界市場を調査対象にし、C-X-Cケモカイン受容体タイプ2の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(DF-2755A、AZD-5069、PAC-G31P、SX-517、その他)、用途別分析(冠動脈疾患、肝移植拒絶、前立腺癌、肺炎症、その他)、市場予測(2021年~2025年)、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報:AstraZeneca Plc、GlaxoSmithKline Plc、ChemoCentryx Inc、Dompe Farmaceutici SpA、Syntrix Biosystems Inc、Novartis AG ・メーカー別販売量、売上、市場シェア ・C-X-Cケモカイン受容体タイプ2の地域別市場分析 ・C-X-Cケモカイン受容体タイプ2の北米市場規模2015-2020:アメリカ、カナダ、メキシコ ・C-X-Cケモカイン受容体タイプ2のヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど ・C-X-Cケモカイン受容体タイプ2のアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど ・C-X-Cケモカイン受容体タイプ2の南米市場規模2015-2020:ブラジル、アルゼンチンなど ・C-X-Cケモカイン受容体タイプ2の中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど ・C-X-Cケモカイン受容体タイプ2の種類別市場規模2015-2020:DF-2755A、AZD-5069、PAC-G31P、SX-517、その他 ・C-X-Cケモカイン受容体タイプ2の用途別市場規模2015-2020:冠動脈疾患、肝移植拒絶、前立腺癌、肺炎症、その他 ・C-X-Cケモカイン受容体タイプ2の世界市場予測2021-2025:地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global C-X-C Chemokine Receptor Type 2 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The C-X-C Chemokine Receptor Type 2 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
C-X-C Chemokine Receptor Type 2 market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, C-X-C Chemokine Receptor Type 2 market has been segmented into
DF-2755A
AZD-5069
PAC-G31P
SX-517
Others
By Application, C-X-C Chemokine Receptor Type 2 has been segmented into:
Cornary Artery Disease
Liver Transplant Rejection
Prostate Cancer
Pulmonary Inflammation
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global C-X-C Chemokine Receptor Type 2 market presented in the report. This section sheds light on the sales growth of different regional and country-level C-X-C Chemokine Receptor Type 2 markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global C-X-C Chemokine Receptor Type 2 market.
The report offers in-depth assessment of the growth and other aspects of the C-X-C Chemokine Receptor Type 2 market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and C-X-C Chemokine Receptor Type 2 Market Share Analysis
C-X-C Chemokine Receptor Type 2 competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, C-X-C Chemokine Receptor Type 2 sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the C-X-C Chemokine Receptor Type 2 sales, revenue and market share for each player covered in this report.
The major players covered in C-X-C Chemokine Receptor Type 2 are:
AstraZeneca Plc
GlaxoSmithKline Plc
ChemoCentryx Inc
Dompe Farmaceutici SpA
Syntrix Biosystems Inc
Novartis AG
Among other players domestic and global, C-X-C Chemokine Receptor Type 2 market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe C-X-C Chemokine Receptor Type 2 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of C-X-C Chemokine Receptor Type 2, with price, sales, revenue and global market share of C-X-C Chemokine Receptor Type 2 in 2018 and 2019.
Chapter 3, the C-X-C Chemokine Receptor Type 2 competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the C-X-C Chemokine Receptor Type 2 breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, C-X-C Chemokine Receptor Type 2 market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe C-X-C Chemokine Receptor Type 2 sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 C-X-C Chemokine Receptor Type 2 Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global C-X-C Chemokine Receptor Type 2 Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 DF-2755A
1.2.3 AZD-5069
1.2.4 PAC-G31P
1.2.5 SX-517
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global C-X-C Chemokine Receptor Type 2 Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cornary Artery Disease
1.3.3 Liver Transplant Rejection
1.3.4 Prostate Cancer
1.3.5 Pulmonary Inflammation
1.3.6 Others
1.4 Overview of Global C-X-C Chemokine Receptor Type 2 Market
1.4.1 Global C-X-C Chemokine Receptor Type 2 Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca Plc
2.1.1 AstraZeneca Plc Details
2.1.2 AstraZeneca Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AstraZeneca Plc SWOT Analysis
2.1.4 AstraZeneca Plc Product and Services
2.1.5 AstraZeneca Plc C-X-C Chemokine Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 GlaxoSmithKline Plc
2.2.1 GlaxoSmithKline Plc Details
2.2.2 GlaxoSmithKline Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 GlaxoSmithKline Plc SWOT Analysis
2.2.4 GlaxoSmithKline Plc Product and Services
2.2.5 GlaxoSmithKline Plc C-X-C Chemokine Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 ChemoCentryx Inc
2.3.1 ChemoCentryx Inc Details
2.3.2 ChemoCentryx Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 ChemoCentryx Inc SWOT Analysis
2.3.4 ChemoCentryx Inc Product and Services
2.3.5 ChemoCentryx Inc C-X-C Chemokine Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Dompe Farmaceutici SpA
2.4.1 Dompe Farmaceutici SpA Details
2.4.2 Dompe Farmaceutici SpA Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Dompe Farmaceutici SpA SWOT Analysis
2.4.4 Dompe Farmaceutici SpA Product and Services
2.4.5 Dompe Farmaceutici SpA C-X-C Chemokine Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Syntrix Biosystems Inc
2.5.1 Syntrix Biosystems Inc Details
2.5.2 Syntrix Biosystems Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Syntrix Biosystems Inc SWOT Analysis
2.5.4 Syntrix Biosystems Inc Product and Services
2.5.5 Syntrix Biosystems Inc C-X-C Chemokine Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novartis AG
2.6.1 Novartis AG Details
2.6.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novartis AG SWOT Analysis
2.6.4 Novartis AG Product and Services
2.6.5 Novartis AG C-X-C Chemokine Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global C-X-C Chemokine Receptor Type 2 Sales and Market Share by Manufacturer (2018-2019)
3.2 Global C-X-C Chemokine Receptor Type 2 Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 C-X-C Chemokine Receptor Type 2 Manufacturer Market Share in 2019
3.3.2 Top 6 C-X-C Chemokine Receptor Type 2 Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global C-X-C Chemokine Receptor Type 2 Sales, Revenue and Market Share by Regions
4.1.1 Global C-X-C Chemokine Receptor Type 2 Sales and Market Share by Regions (2015-2020)
4.1.2 Global C-X-C Chemokine Receptor Type 2 Revenue and Market Share by Regions (2015-2020)
4.2 North America C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020)
4.3 Europe C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020)
4.5 South America C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America C-X-C Chemokine Receptor Type 2 Sales, Revenue and Market Share by Country
5.1.1 North America C-X-C Chemokine Receptor Type 2 Sales and Market Share by Country (2015-2020)
5.1.2 North America C-X-C Chemokine Receptor Type 2 Revenue and Market Share by Country (2015-2020)
5.2 United States C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020)
5.3 Canada C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020)
5.4 Mexico C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe C-X-C Chemokine Receptor Type 2 Sales, Revenue and Market Share by Country
6.1.1 Europe C-X-C Chemokine Receptor Type 2 Sales and Market Share by Country (2015-2020)
6.1.2 Europe C-X-C Chemokine Receptor Type 2 Revenue and Market Share by Country (2015-2020)
6.2 Germany C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020)
6.3 UK C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020)
6.4 France C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020)
6.5 Russia C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020)
6.6 Italy C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific C-X-C Chemokine Receptor Type 2 Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific C-X-C Chemokine Receptor Type 2 Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific C-X-C Chemokine Receptor Type 2 Revenue and Market Share by Regions (2015-2020)
7.2 China C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020)
7.3 Japan C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020)
7.4 Korea C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020)
7.5 India C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020)
7.6 Southeast Asia C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020)
7.7 Australia C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America C-X-C Chemokine Receptor Type 2 Sales, Revenue and Market Share by Country
8.1.1 South America C-X-C Chemokine Receptor Type 2 Sales and Market Share by Country (2015-2020)
8.1.2 South America C-X-C Chemokine Receptor Type 2 Revenue and Market Share by Country (2015-2020)
8.2 Brazil C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020)
8.3 Argentina C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa C-X-C Chemokine Receptor Type 2 Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa C-X-C Chemokine Receptor Type 2 Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa C-X-C Chemokine Receptor Type 2 Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020)
9.3 Turkey C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020)
9.4 Egypt C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020)
9.5 South Africa C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global C-X-C Chemokine Receptor Type 2 Sales and Market Share by Type (2015-2020)
10.2 Global C-X-C Chemokine Receptor Type 2 Revenue and Market Share by Type (2015-2020)
10.3 Global C-X-C Chemokine Receptor Type 2 Price by Type (2015-2020)
11 Global C-X-C Chemokine Receptor Type 2 Market Segment by Application
11.1 Global C-X-C Chemokine Receptor Type 2 Sales Market Share by Application (2015-2020)
11.2 Global C-X-C Chemokine Receptor Type 2 Revenue Market Share by Application (2015-2020)
11.3 Global C-X-C Chemokine Receptor Type 2 Price by Application (2015-2020)
12 Market Forecast
12.1 Global C-X-C Chemokine Receptor Type 2 Sales, Revenue and Growth Rate (2021-2025)
12.2 C-X-C Chemokine Receptor Type 2 Market Forecast by Regions (2021-2025)
12.2.1 North America C-X-C Chemokine Receptor Type 2 Market Forecast (2021-2025)
12.2.2 Europe C-X-C Chemokine Receptor Type 2 Market Forecast (2021-2025)
12.2.3 Asia-Pacific C-X-C Chemokine Receptor Type 2 Market Forecast (2021-2025)
12.2.4 South America C-X-C Chemokine Receptor Type 2 Market Forecast (2021-2025)
12.2.5 Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Forecast (2021-2025)
12.3 C-X-C Chemokine Receptor Type 2 Market Forecast by Type (2021-2025)
12.3.1 Global C-X-C Chemokine Receptor Type 2 Sales Forecast by Type (2021-2025)
12.3.2 Global C-X-C Chemokine Receptor Type 2 Market Share Forecast by Type (2021-2025)
12.4 C-X-C Chemokine Receptor Type 2 Market Forecast by Application (2021-2025)
12.4.1 Global C-X-C Chemokine Receptor Type 2 Sales Forecast by Application (2021-2025)
12.4.2 Global C-X-C Chemokine Receptor Type 2 Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global C-X-C Chemokine Receptor Type 2 Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of C-X-C Chemokine Receptor Type 2 by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global C-X-C Chemokine Receptor Type 2 Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. AstraZeneca Plc Basic Information, Manufacturing Base and Competitors
Table 8. AstraZeneca Plc C-X-C Chemokine Receptor Type 2 Major Business
Table 9. AstraZeneca Plc C-X-C Chemokine Receptor Type 2 Total Revenue (USD Million) (2018-2019)
Table 10. AstraZeneca Plc SWOT Analysis
Table 11. AstraZeneca Plc C-X-C Chemokine Receptor Type 2 Product and Services
Table 12. AstraZeneca Plc C-X-C Chemokine Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 14. GlaxoSmithKline Plc C-X-C Chemokine Receptor Type 2 Major Business
Table 15. GlaxoSmithKline Plc C-X-C Chemokine Receptor Type 2 Total Revenue (USD Million) (2018-2019)
Table 16. GlaxoSmithKline Plc SWOT Analysis
Table 17. GlaxoSmithKline Plc C-X-C Chemokine Receptor Type 2 Product and Services
Table 18. GlaxoSmithKline Plc C-X-C Chemokine Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. ChemoCentryx Inc Basic Information, Manufacturing Base and Competitors
Table 20. ChemoCentryx Inc C-X-C Chemokine Receptor Type 2 Major Business
Table 21. ChemoCentryx Inc C-X-C Chemokine Receptor Type 2 Total Revenue (USD Million) (2018-2019)
Table 22. ChemoCentryx Inc SWOT Analysis
Table 23. ChemoCentryx Inc C-X-C Chemokine Receptor Type 2 Product and Services
Table 24. ChemoCentryx Inc C-X-C Chemokine Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Dompe Farmaceutici SpA Basic Information, Manufacturing Base and Competitors
Table 26. Dompe Farmaceutici SpA C-X-C Chemokine Receptor Type 2 Major Business
Table 27. Dompe Farmaceutici SpA C-X-C Chemokine Receptor Type 2 Total Revenue (USD Million) (2018-2019)
Table 28. Dompe Farmaceutici SpA SWOT Analysis
Table 29. Dompe Farmaceutici SpA C-X-C Chemokine Receptor Type 2 Product and Services
Table 30. Dompe Farmaceutici SpA C-X-C Chemokine Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Syntrix Biosystems Inc Basic Information, Manufacturing Base and Competitors
Table 32. Syntrix Biosystems Inc C-X-C Chemokine Receptor Type 2 Major Business
Table 33. Syntrix Biosystems Inc C-X-C Chemokine Receptor Type 2 Total Revenue (USD Million) (2018-2019)
Table 34. Syntrix Biosystems Inc SWOT Analysis
Table 35. Syntrix Biosystems Inc C-X-C Chemokine Receptor Type 2 Product and Services
Table 36. Syntrix Biosystems Inc C-X-C Chemokine Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 38. Novartis AG C-X-C Chemokine Receptor Type 2 Major Business
Table 39. Novartis AG C-X-C Chemokine Receptor Type 2 Total Revenue (USD Million) (2018-2019)
Table 40. Novartis AG SWOT Analysis
Table 41. Novartis AG C-X-C Chemokine Receptor Type 2 Product and Services
Table 42. Novartis AG C-X-C Chemokine Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Global C-X-C Chemokine Receptor Type 2 Sales by Manufacturer (2018-2019) (K Pcs)
Table 44. Global C-X-C Chemokine Receptor Type 2 Revenue by Manufacturer (2018-2019) (USD Million)
Table 45. Global C-X-C Chemokine Receptor Type 2 Sales by Regions (2015-2020) (K Pcs)
Table 46. Global C-X-C Chemokine Receptor Type 2 Sales Market Share by Regions (2015-2020)
Table 47. Global C-X-C Chemokine Receptor Type 2 Revenue by Regions (2015-2020) (USD Million)
Table 48. North America C-X-C Chemokine Receptor Type 2 Sales by Countries (2015-2020) (K Pcs)
Table 49. North America C-X-C Chemokine Receptor Type 2 Sales Market Share by Countries (2015-2020)
Table 50. North America C-X-C Chemokine Receptor Type 2 Revenue by Countries (2015-2020) (USD Million)
Table 51. North America C-X-C Chemokine Receptor Type 2 Revenue Market Share by Countries (2015-2020)
Table 52. Europe C-X-C Chemokine Receptor Type 2 Sales by Countries (2015-2020) (K Pcs)
Table 53. Europe C-X-C Chemokine Receptor Type 2 Sales Market Share by Countries (2015-2020)
Table 54. Europe C-X-C Chemokine Receptor Type 2 Revenue by Countries (2015-2020) (USD Million)
Table 55. Asia-Pacific C-X-C Chemokine Receptor Type 2 Sales by Regions (2015-2020) (K Pcs)
Table 56. Asia-Pacific C-X-C Chemokine Receptor Type 2 Sales Market Share by Regions (2015-2020)
Table 57. Asia-Pacific C-X-C Chemokine Receptor Type 2 Revenue by Regions (2015-2020) (USD Million)
Table 58. South America C-X-C Chemokine Receptor Type 2 Sales by Countries (2015-2020) (K Pcs)
Table 59. South America C-X-C Chemokine Receptor Type 2 Sales Market Share by Countries (2015-2020)
Table 60. South America C-X-C Chemokine Receptor Type 2 Revenue by Countries (2015-2020) (USD Million)
Table 61. South America C-X-C Chemokine Receptor Type 2 Revenue Market Share by Countries (2015-2020)
Table 62. Middle East & Africa C-X-C Chemokine Receptor Type 2 Sales by Countries (2015-2020) (K Pcs)
Table 63. Middle East & Africa C-X-C Chemokine Receptor Type 2 Sales Market Share by Countries (2015-2020)
Table 64. Middle East & Africa C-X-C Chemokine Receptor Type 2 Revenue by Countries (2015-2020) (USD Million)
Table 65. Middle East & Africa C-X-C Chemokine Receptor Type 2 Revenue Market Share by Countries (2015-2020)
Table 66. Global C-X-C Chemokine Receptor Type 2 Sales by Type (2015-2020) (K Pcs)
Table 67. Global C-X-C Chemokine Receptor Type 2 Sales Share by Type (2015-2020)
Table 68. Global C-X-C Chemokine Receptor Type 2 Revenue by Type (2015-2020) (USD Million)
Table 69. Global C-X-C Chemokine Receptor Type 2 Revenue Share by Type (2015-2020)
Table 70. Global C-X-C Chemokine Receptor Type 2 Sales by Application (2015-2020) (K Pcs)
Table 71. Global C-X-C Chemokine Receptor Type 2 Sales Share by Application (2015-2020)
Table 72. Global C-X-C Chemokine Receptor Type 2 Sales Forecast by Regions (2021-2025) (K Pcs)
Table 73. Global C-X-C Chemokine Receptor Type 2 Market Share Forecast by Regions (2021-2025)
Table 74. Global C-X-C Chemokine Receptor Type 2 Sales Forecast by Type (2021-2025) (K Pcs)
Table 75. Global C-X-C Chemokine Receptor Type 2 Market Share Forecast by Type (2021-2025)
Table 76. Global C-X-C Chemokine Receptor Type 2 Sales Forecast by Application (2021-2025)
Table 77. Global C-X-C Chemokine Receptor Type 2 Market Share Forecast by Application (2021-2025)
Table 78. Direct Channel Pros & Cons
Table 79. Indirect Channel Pros & Cons
Table 80. Distributors/Traders/ Dealers List
List of Figures
Figure 1. C-X-C Chemokine Receptor Type 2 Picture
Figure 2. Global Sales Market Share of C-X-C Chemokine Receptor Type 2 by Type in 2019
Figure 3. DF-2755A Picture
Figure 4. AZD-5069 Picture
Figure 5. PAC-G31P Picture
Figure 6. SX-517 Picture
Figure 7. Others Picture
Figure 8. C-X-C Chemokine Receptor Type 2 Sales Market Share by Application in 2018
Figure 9. Cornary Artery Disease Picture
Figure 10. Liver Transplant Rejection Picture
Figure 11. Prostate Cancer Picture
Figure 12. Pulmonary Inflammation Picture
Figure 13. Others Picture
Figure 14. Global C-X-C Chemokine Receptor Type 2 Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States C-X-C Chemokine Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada C-X-C Chemokine Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico C-X-C Chemokine Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany C-X-C Chemokine Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France C-X-C Chemokine Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK C-X-C Chemokine Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia C-X-C Chemokine Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy C-X-C Chemokine Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China C-X-C Chemokine Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan C-X-C Chemokine Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea C-X-C Chemokine Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India C-X-C Chemokine Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia C-X-C Chemokine Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia C-X-C Chemokine Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil C-X-C Chemokine Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt C-X-C Chemokine Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia C-X-C Chemokine Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa C-X-C Chemokine Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey C-X-C Chemokine Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global C-X-C Chemokine Receptor Type 2 Sales Market Share by Manufacturer in 2019
Figure 35. Global C-X-C Chemokine Receptor Type 2 Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 C-X-C Chemokine Receptor Type 2 Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 C-X-C Chemokine Receptor Type 2 Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 40. Global C-X-C Chemokine Receptor Type 2 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global C-X-C Chemokine Receptor Type 2 Revenue Market Share by Regions (2015-2020)
Figure 42. Global C-X-C Chemokine Receptor Type 2 Revenue Market Share by Regions in 2018
Figure 43. North America C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020)
Figure 44. Europe C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020)
Figure 46. South America C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020)
Figure 48. North America C-X-C Chemokine Receptor Type 2 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America C-X-C Chemokine Receptor Type 2 Sales Market Share by Countries (2015-2020)
Figure 50. North America C-X-C Chemokine Receptor Type 2 Sales Market Share by Countries in 2018
Figure 51. North America C-X-C Chemokine Receptor Type 2 Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America C-X-C Chemokine Receptor Type 2 Revenue Market Share by Countries in 2018
Figure 53. United States C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Canada C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Mexico C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. Europe C-X-C Chemokine Receptor Type 2 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe C-X-C Chemokine Receptor Type 2 Revenue Market Share by Countries (2015-2020)
Figure 58. Europe C-X-C Chemokine Receptor Type 2 Revenue Market Share by Countries in 2019
Figure 59. Germany C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. UK C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. France C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Russia C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Italy C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Asia-Pacific C-X-C Chemokine Receptor Type 2 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific C-X-C Chemokine Receptor Type 2 Sales Market Share by Regions 2019
Figure 66. Asia-Pacific C-X-C Chemokine Receptor Type 2 Revenue Market Share by Regions 2019
Figure 67. China C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Japan C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Korea C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. India C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. Southeast Asia C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. South America C-X-C Chemokine Receptor Type 2 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America C-X-C Chemokine Receptor Type 2 Sales Market Share by Countries in 2019
Figure 74. South America C-X-C Chemokine Receptor Type 2 Revenue Market Share by Countries in 2019
Figure 75. Brazil C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 76. Argentina C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 77. Middle East and Africa C-X-C Chemokine Receptor Type 2 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa C-X-C Chemokine Receptor Type 2 Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa C-X-C Chemokine Receptor Type 2 Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa C-X-C Chemokine Receptor Type 2 Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Egypt C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Turkey C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. South Africa C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 85. Global C-X-C Chemokine Receptor Type 2 Sales and Growth Rate (2021-2025) (K Pcs)
Figure 86. Global C-X-C Chemokine Receptor Type 2 Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales C-X-C Chemokine Receptor Type 2 Market Forecast (2021-2025) (K Pcs)
Figure 88. Europe Sales C-X-C Chemokine Receptor Type 2 Market Forecast (2021-2025) (K Pcs)
Figure 89. Asia-Pacific Sales C-X-C Chemokine Receptor Type 2 Market Forecast (2021-2025) (K Pcs)
Figure 90. South America Sales C-X-C Chemokine Receptor Type 2 Market Forecast (2021-2025) (K Pcs)
Figure 91. Middle East & Africa Sales C-X-C Chemokine Receptor Type 2 Market Forecast (2021-2025) (K Pcs)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel